Latest news & press releases

  1 - 2 Next

April 2014

Sentinel Oncology and Oncothyreon Collaborate to Develop and Commercialise Small Molecule Chk1 Inhibitors

Cambridge, UK, 22nd April 2014: Sentinel Oncology Ltd. (Sentinel), the small molecule drug discovery company, today announced… read more

May 2013

Sentinel Oncology achieves milestone in Horizon Discovery agreement

Cambridge, UK, 8th May 2013: Sentinel Oncology (Sentinel) today announced it has achieved a research milestone in its collaboration… read more

March 2013

Sentinel Oncology begin Discovery Collaboration with Professor Anthony Chalmers

Sentinel Oncology Limited (Sentinel) is pleased to announce the start of a collaboration with Professor Anthony Chalmers… read more

November 2012

Sentinel Oncology awarded Biomedical Catalyst funding to develop cancer drug

Sentinel Oncology is pleased to announce that it was recently awarded an Early Stage grant as part of the government-backed… read more

October 2012

Sentinel Oncology wins European award

Sentinel Oncology recently received an award from Enterprise Europe Network (EEN) for their role in an SME consortium… read more

August 2012

Sentinel Oncology awarded Biomedical Catalyst feasibility grant

Sentinel Oncology is pleased to announce that it was recently awarded a feasibility grant as part of the government-backed… read more

January 2012

Sentinel Oncology awarded Technology Strategy Board Proof of Concept grant

Sentinel Oncology is pleased to announce the recent award from the Technology Strategy Board of a proof of concept grant… read more

April 2011

Sentinel Oncology awarded Eurostars grant for R&D

Sentinel Oncology, which is focused on the discovery of novel treatments for cancer, has been awarded a grant under the… read more

April 2010

Sentinel Oncology awarded grant to further cancer research

Sentinel Oncology are pleased to announce that they have recently been awarded a development grant from the East of England… read more

January 2009

Sentinel Oncology Appoints John Dixon To Board Of Directors

Sentinel Oncology is pleased to announce the appointment of Dr. John Dixon to the board of Directors.… read more

  1 - 2 Next

 

Events

Sentinel Oncology will be participating in the following events

 

23rd - 26th June 2014

BIO - San Diego

 

3rd - 5th November 2014

BIO Europe - Frankfurt